1. Donoghue, Lauren J, Markovetz, Matthew R, Morrison, Cameron B, Hill, David B, Kelada, Samir N P. 2023. BPIFB1 loss alters airway mucus properties and diminishes mucociliary clearance. In American journal of physiology. Lung cellular and molecular physiology, 325, L765-L775. doi:10.1152/ajplung.00390.2022. https://pubmed.ncbi.nlm.nih.gov/37847709/
2. Saferali, Aabida, Tang, Anthony C, Strug, Lisa J, Sandford, Andrew J, Turvey, Stuart E. 2020. Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1. In PloS one, 15, e0227067. doi:10.1371/journal.pone.0227067. https://pubmed.ncbi.nlm.nih.gov/31931521/
3. Jiang, Xianjie, Deng, Xiangying, Wang, Jie, Xiong, Wei, Zeng, Zhaoyang. 2021. BPIFB1 inhibits vasculogenic mimicry via downregulation of GLUT1-mediated H3K27 acetylation in nasopharyngeal carcinoma. In Oncogene, 41, 233-245. doi:10.1038/s41388-021-02079-8. https://pubmed.ncbi.nlm.nih.gov/34725462/
4. Cai, Jiaodi, Xiao, Li, Liu, Jiao, Liao, Zhiming, Chen, Guoqun. 2024. BPIFB1, Serving as a Downstream Effector of EBV-miR-BART4, Blocks Immune Escape of Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression. In Biochemical genetics, 63, 540-556. doi:10.1007/s10528-024-10719-3. https://pubmed.ncbi.nlm.nih.gov/38467887/
5. Chai, Tianci, Liu, Yinji, Zeng, Yuwei, Kang, Sung-Yoon, Li, Jie. 2024. CLCA1 and BPIFB1 are potential novel biomarkers for asthma: an iTRAQ analysis. In Journal of thoracic disease, 16, 6955-6968. doi:10.21037/jtd-24-1366. https://pubmed.ncbi.nlm.nih.gov/39552876/
智鼠故事 
